These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25845663)

  • 1. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
    Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
    Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet.
    Cansby E; Amrutkar M; Mannerås Holm L; Nerstedt A; Reyahi A; Stenfeldt E; Borén J; Carlsson P; Smith U; Zierath JR; Mahlapuu M
    FASEB J; 2013 Sep; 27(9):3660-71. PubMed ID: 23729594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle.
    Chursa U; Nuñez-Durán E; Cansby E; Amrutkar M; Sütt S; Ståhlman M; Olsson BM; Borén J; Johansson ME; Bäckhed F; Johansson BR; Sihlbom C; Mahlapuu M
    Diabetologia; 2017 Mar; 60(3):553-567. PubMed ID: 27981357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice.
    Nuñez-Durán E; Chanclón B; Sütt S; Real J; Marschall HU; Wernstedt Asterholm I; Cansby E; Mahlapuu M
    J Endocrinol; 2017 Jul; 234(1):15-27. PubMed ID: 28442507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans.
    Amrutkar M; Kern M; Nuñez-Durán E; Ståhlman M; Cansby E; Chursa U; Stenfeldt E; Borén J; Blüher M; Mahlapuu M
    Diabetologia; 2016 Feb; 59(2):341-53. PubMed ID: 26553096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STK25 is a critical determinant in nonalcoholic steatohepatitis.
    Amrutkar M; Chursa U; Kern M; Nuñez-Durán E; Ståhlman M; Sütt S; Borén J; Johansson BR; Marschall HU; Blüher M; Mahlapuu M
    FASEB J; 2016 Oct; 30(10):3628-3643. PubMed ID: 27421788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine/threonine protein kinase 25 (STK25): a novel negative regulator of lipid and glucose metabolism in rodent and human skeletal muscle.
    Nerstedt A; Cansby E; Andersson CX; Laakso M; Stančáková A; Blüher M; Smith U; Mahlapuu M
    Diabetologia; 2012 Jun; 55(6):1797-807. PubMed ID: 22391949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease.
    Cansby E; Caputo M; Gao L; Kulkarni NM; Nerstedt A; Ståhlman M; Borén J; Porosk R; Soomets U; Pedrelli M; Parini P; Marschall HU; Nyström J; Howell BW; Mahlapuu M
    JCI Insight; 2020 Dec; 5(24):. PubMed ID: 33170807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STK25 regulates oxidative capacity and metabolic efficiency in adipose tissue.
    Sütt S; Cansby E; Paul A; Amrutkar M; Nuñez-Durán E; Kulkarni NM; Ståhlman M; Borén J; Laurencikiene J; Howell BW; Enerbäck S; Mahlapuu M
    J Endocrinol; 2018 Sep; 238(3):187-202. PubMed ID: 29794231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet.
    Hwang B; Jeoung NH; Harris RA
    Biochem J; 2009 Sep; 423(2):243-52. PubMed ID: 19627255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
    Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CTRP1 disrupts glucose and lipid homeostasis.
    Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.
    Nuñez-Durán E; Aghajan M; Amrutkar M; Sütt S; Cansby E; Booten SL; Watt A; Ståhlman M; Stefan N; Häring HU; Staiger H; Borén J; Marschall HU; Mahlapuu M
    Hepatol Commun; 2018 Jan; 2(1):69-83. PubMed ID: 29404514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice.
    Romanatto T; Fiamoncini J; Wang B; Curi R; Kang JX
    Biochim Biophys Acta; 2014 Feb; 1842(2):186-91. PubMed ID: 24211484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver.
    Nerstedt A; Kurhe Y; Cansby E; Caputo M; Gao L; Vorontsov E; Ståhlman M; Nuñez-Durán E; Borén J; Marschall HU; Mashek DG; Saunders DN; Sihlbom C; Hoy AJ; Mahlapuu M
    J Lipid Res; 2020 Feb; 61(2):178-191. PubMed ID: 31857389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
    Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
    J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal relationship between diet-induced steatosis and onset of insulin/leptin resistance in male Wistar rats.
    Zhang L; Song H; Ge Y; Ji G; Yao Z
    PLoS One; 2015; 10(2):e0117008. PubMed ID: 25658428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.